Type 1 diabetes

HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives

DiabetologiaPublished Cohort study

Authors' conclusion

Progression to Stages 2 and 3 of type 1 diabetes increases with HOMA-IR and decreases with the Matsuda Index after adjustments for insulin secretion. Indicators of insulin secretion appear helpful for interpreting associations of progression to type 1 diabetes with HOMA-IR or the Matsuda Index in AAb-positive relatives.

Study context

Population
AAb-positive relatives of individuals with T1D, TrialNet Pathway to Prevention
Participants
6,256 relatives
Exposure
Tertiles of HOMA-IR and Matsuda Index, adjusted for insulin secretion
Outcome
Transitions through stages of T1D: Not Staged to Stage 1, Stage 1 to Stage 2, and progression to Stage 3
Methodological detailsCox regression, tertiles of HOMA-IR and Matsuda Index
  • Cox regression
  • Tertiles of HOMA-IR and Matsuda Index

Main finding

As reported in the abstract

Stage 1 to Stage 2, HOMA-IR: HR

1.71

p<0.0001

Stage 1 to Stage 2, Matsuda Index: HR

0.40

p<0.0001

Stages 1 or 2 to Stage 3, HOMA-IR: HR

1.98

p<0.0001

Stages 1 or 2 to Stage 3, Matsuda Index: HR

0.46

p<0.0001

Observational data: associations, not effects.

Further findings

Association of HOMA-IR and Matsuda Index with baseline age and BMI percentile (BMIp)

Strong associations of HOMA-IR (positive) and Matsuda Index (inverse) with baseline age and BMIp
P < 0.0001

Progression to Stage 3 without adjustments

Without adjustments, associations were inverse for HOMA-IR and positive for Matsuda Index, opposite in directionality to adjusted
  • Unadjusted

Original publication

HOMA-IR and the Matsuda Index as predictors of progression to type 1 diabetes in autoantibody-positive relatives. Diabetologia. Published 2 November 2023. doi:10.1007/s00125-023-06034-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.